Scribd Logo
Upload

Welcome to Scribd!

  • 7 views

    Anti HCV or HbsAg

    Uploaded by

    Harsh Sharma

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Anti HCV or HbsAg

    Uploaded by

    Harsh Sharma
    7 views2 pages

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    7 views2 pages

    Anti HCV or HbsAg

    Uploaded by

    Harsh Sharma

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 2

    DIAGNOSTIC REPORT

    CLIENT CODE : C000026630 Cert. No. MC-2722

    CLIENT'S NAME AND ADDRESS : SRL Ltd


    KARNAL LAB - WALK-IN C/O HEALTH AFFAIRS,416,ASHOKA COLONY OPP.KALPANA CHAWLA
    SRL LIMITED, C/O THE HEALTH AFFAIRS, 416, ASHOKA COLONY, MEDICAL COLLEGE
    OPP. KALPANA CHAWLA MEDICAL COLLEGE, KARNAL, 132001
    KARNAL 132001 HARYANA, INDIA
    HARYANA INDIA Tel : 0184-2201001,4030001,4030010, Fax :
    0184-4030001 9541210001 CIN - U74899PB1995PLC045956
    Email : [email protected]

    PATIENT NAME : HARI OM PATIENT ID : HARIM081219980

    ACCESSION NO : 0070UK005159 AGE : 22 Years SEX : Male

    DRAWN : 18/11/2021 09:21 RECEIVED : 18/11/2021 09:49 REPORTED : 18/11/2021 12:25

    REFERRING DOCTOR : SELF CLIENT PATIENT ID :

    Test Report Status Final Results Biological Reference Interval Units

    SEROLOGY

    HCV ABS, SERUM


    HEPATITIS C ABS NON REACTIVE NON REACTIVE
    METHOD : IMMUNOFILTERATION

    Comments

    COMMENTS :-HCV & HEPACARD TEST IS ONLY FOR SCREENING PURPOSES. ALL REACTIVE RESULTS SHOULD BE CONFIRMED BY CONFIRMATORY
    TEST.
    HEPATITIS B SURFACE ANTIGEN, SERUM
    HEPATITIS B SURFACE ANTIGEN NON REACTIVE NON REACTIVE
    METHOD : IMMUNOCHROMATOGRAPHY

    Interpretation(s)
    HCV ABS, SERUM-Hepatitis C Virus (HCV) is a blood borne flavivirus. It is one of the most important causes of post-blood transfusion as well as community acquired non-A
    non-B hepatitis and chronic liver failure. Although the majority of infected individuals may be asymptomatic, HCV infection may develop into chronic hepatitis, cirrhosis and/or
    increased risk of hepatocellular carcinoma.

    Notes & Limitations:


    - HCV antibody is typically not detected until approximately 14 weeks after infection (or 5 weeks after appearance of the first biochemical marker of illness) and is almost
    always detectable by the late convalescent stage of infection. - A negative result may also be observed due to loss of HCV antigen, years following resolution of infection.
    Infants born to hepatitis C infected mothers may have delayed seroconversion to anti-HCV. Hence a negative result should be evaluated cautiously with respect to clinical
    findings. It is to be noted that absence of HCV antibodies after 14 weeks of exposure is strong evidence against HCV infection.
    - Presence of HCV antibodies does not imply an active Hepatitis C infection but is indicative of both past and/or recent infection .It has been reported that as many as 90% of
    individuals receiving intravenous commercial immunoglobulin test falsely positive for HCV antibody. Also,patients with autoimmune liver disease may show a false positive
    HCV antibody result. Hence it is advisable to confirm a positive antibody result with a supplemental test. A positive result when followed by a positive supplemental test (i.e.
    HCV-RNA-PCR) suggests active hepatitis C infection.
    HEPATITIS B SURFACE ANTIGEN, SERUM-
    Hepatitis B is caused by infection with HBV, a enveloped DNA agent that is classified as hepadnavirus.This test detects the presence of viral surface antigen (HbsAg) in serum
    sample and is indicative of an active HBV infection, either acute or chronic.

    Test Utility:
    HbsAg is the first serologic marker appearing in the serum 6-16 weeks following hepatitis B viral infection. In typical HBV infection, HBsAg will be detected 2-4 weeks before
    the liver enzyme levels (ALT) become abnormal and 3-5 weeks before patient develops jaundice.In acute cases HbsAg usually disappears 1-2 months after the onset of
    symptoms.Persistence of HbsAg for more than 6 months indicates development of either a chronic carrier state or chronic liver disease.The presence of HbsAg is frequently
    associated with infectivity. HbsAg when accompanied by Hepatitis Be antigen and/or hepatitis B viral DNA almost always indicates infectivity.

    Limitations:
    - For diagnostic purposes, results should be used in conjunction with patient history and other hepatitis markers for diagnosis of acute or chronic infection. If the antibody
    results are inconsistent with clinical evidence, additional testing is suggested to confirm the result.
    - HBsAg detection will only indicate the presence of surface antigens in the serum and should not be used as the sole criteria for diagnosis, staging or monitoring of HBV
    infection This test may be negative during ""window period"" i.e. after disappearance of anti-HBs.
    - The current assay being a highly sensitive test , may yield a small percentage of false positive reports. Hence all HbsAg positive specimens should be confirmed with an
    assay based upon Neutralisation of Human anti Hepatitis B Surface antibody.
    **End Of Report**
    Please visit www.srlworld.com for related Test Information for this accession

    Dr. Shaveta Arora, MD


    Pathologist

    Page 1 Of 2

    Scan to View Details


    DIAGNOSTIC REPORT

    CLIENT CODE : C000026630

    CLIENT'S NAME AND ADDRESS : SRL Ltd


    KARNAL LAB - WALK-IN C/O HEALTH AFFAIRS,416,ASHOKA COLONY OPP.KALPANA CHAWLA
    SRL LIMITED, C/O THE HEALTH AFFAIRS, 416, ASHOKA COLONY, MEDICAL COLLEGE
    OPP. KALPANA CHAWLA MEDICAL COLLEGE, KARNAL, 132001
    KARNAL 132001 HARYANA, INDIA
    HARYANA INDIA Tel : 0184-2201001,4030001,4030010, Fax :
    0184-4030001 9541210001 CIN - U74899PB1995PLC045956
    Email : [email protected]

    PATIENT NAME : HARI OM PATIENT ID : HARIM081219980

    ACCESSION NO : 0070UK005159 AGE : 22 Years SEX : Male

    DRAWN : 18/11/2021 09:21 RECEIVED : 18/11/2021 09:49 REPORTED : 18/11/2021 12:25

    REFERRING DOCTOR : SELF CLIENT PATIENT ID :

    Test Report Status Final Results Biological Reference Interval Units

    CONDITIONS OF LABORATORY TESTING & REPORTING

    1. It is presumed that the test sample belongs to the 5. The results of a laboratory test are dependent on
    patient named or identified in the test requisition form. the quality of the sample as well as the assay
    2. All Tests are performed and reported as per the technology.
    turnaround time stated in the SRL Directory of services 6. Result delays could be because of uncontrolled
    (DOS). circumstances. e.g. assay run failure.
    3. SRL confirms that all tests have been performed or 7. Tests parameters marked by asterisks are excluded
    assayed with highest quality standards, clinical safety & from the “scope" of NABL accredited tests. (If
    technical integrity. laboratory is accredited).
    4. A requested test might not be performed if: 8. Laboratory results should be correlated with clinical
    a. Specimen received is insufficient or inappropriate information to determine Final diagnosis.
    specimen quality is unsatisfactory 9. Test results are not valid for Medico- legal purposes.
    b. Incorrect specimen type 10. In case of queries or unexpected test results please
    c. Request for testing is withdrawn by the ordering call at SRL customer care (91115 91115). Post proper
    doctor or patient investigation repeat analysis may be carried out.
    d. There is a discrepancy between the label on the
    specimen container and the name on the test
    requisition form

    SRL Limited
    Fortis Hospital, Sector 62, Phase VIII,
    Mohali 160062

    Page 2 Of 2

    Scan to View Details

    You might also like